2002
DOI: 10.1054/bjps.2002.3948
|View full text |Cite
|
Sign up to set email alerts
|

Incomplete excision of basal cell carcinoma: a prospective multicentre audit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
64
4
3

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 74 publications
(77 citation statements)
references
References 22 publications
6
64
4
3
Order By: Relevance
“…O sexo masculino é atribuído como fator de risco para o desenvolvimento de neoplasias cutâneas não melanoma em alguns estudos. 6,10 O sexo feminino correspondeu à parcela mais afetada por lesões em regiões com maior chance de falha terapêutica, metástase e recidivas, 11 como a nasal, periorbitária e malar.…”
Section: Discussionunclassified
See 1 more Smart Citation
“…O sexo masculino é atribuído como fator de risco para o desenvolvimento de neoplasias cutâneas não melanoma em alguns estudos. 6,10 O sexo feminino correspondeu à parcela mais afetada por lesões em regiões com maior chance de falha terapêutica, metástase e recidivas, 11 como a nasal, periorbitária e malar.…”
Section: Discussionunclassified
“…11,12 De acordo com a região anatômica facial, existe variação quanto ao risco de metástases, comprometimento de bordas, agressividade do tumor e, portanto, maior chance de insucesso do tratamento cirúrgico. 11,13 Isso se deve, entre outras causas, pela tendência de se realizar margens de ressecção mais conservadoras em áreas nobres do corpo, como a face.…”
Section: Anosunclassified
“…On the basis of the best available literature, the most useful stratification of BCC is provided by the National Comprehensive Cancer Network (NCCN) Guidelines (for recommendation, see Table II; for level of evidence/strength of recommendation, see Table III). 2,3,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] The NCCN stratification, listed in Table IV, takes both clinical and pathologic parameters into account and is based on a combination of available evidence and expert multidisciplinary opinion, including representatives from dermatology, dermatopathology, head and neck surgery, plastic surgery, and surgical, radiation, and medical oncology. Treatment recommendations throughout the current guidelines are based on this stratification.…”
Section: Grading and Stagingmentioning
confidence: 99%
“…When the clinician is submitting biopsy tissue for histopathologic diagnosis, the work group recommends that whenever possible and appropriate, key elements of patient demographics, clinical presentation, and clinical history should be provided to the pathologist (see Table VI; for level of evidence/ strength of recommendations, see Table III). These include patient age and biologic sex, [17][18][19][20][21][22][23][24][25] anatomic location, [17][18][19][20][22][23][24][25][26] and any history of treatment at the same anatomic site. 17,18,22,23 Additional desirable relevant information includes the clinical size of the lesion 17,18,[20][21][22][23][24][25][26] and whether the patient currently, or previously encountered additional risk factors, such as immunosuppression, radiation treatment, or solid organ transplantation.…”
Section: Clinical and Pathologic Informationmentioning
confidence: 99%
See 1 more Smart Citation